Healthcare
Discover news, funding updates, regulatory changes, and sector insights impacting the health care industry in India.
Healthcare
Bharat's Covid shot shows high immune response, further study needed for elderly
A COVID-19 vaccine developed by India's Bharat Biotech is safe and has shown high levels of antibody response in a ......
Healthcare
Belgian impact investor to take reins of IL&FS PE fund
A Belgian impact investor with healthcare bets in India is set to take over the management of IL&FS’s only operational...
Healthcare
Bharat Biotech says Covid vaccine shows 81% interim efficacy
Bharat Biotech's homegrown Covid-19 vaccine has shown an interim vaccine efficacy of 81% in late-stage clinical trials, the...
Healthcare
Market-bound healthcare chain looks to buy hospital turned around by PE
Ahead of its IPO, KIMS is trying to buy a Bengaluru hospital on the cheap, which turned around under a ......
Healthcare
UK to get 10 mn AstraZeneca Covid vaccine doses from Serum Institute
The UK will receive 10 million AstraZeneca Covid-19 vaccine doses made by the Serum Institute of India (SII), the UK ......
Healthcare
Steadview pares API maker stake in third exit in a month
In its third exit from an Indian portfolio company within a month, Asia focussed hedge fund Steadview Capital has sold ......
Healthcare
Tano Capital backed Windlas ropes in bankers for IPO
Tano Capital backed pharmaceuticals company Windlas Biotech Pvt. Ltd has signed up investment bankers for its public float, two...
Healthcare
Healthcare investor OrbiMed raises Asia private equity fund, overshoots target
Healthcare investment firm OrbiMed has raised its fourth Asia private equity fund primarily focused on China and India, overshooting...
Healthcare
J&J working to bring very high capacity plant in India: Exec
Johnson & Johnson is waiting on regulatory approval of a new, larger plant operated by contract manufacturer Catalent Inc...
Healthcare
Steadview Capital makes partial exit from bulk drugs firm
Alternative investment firm Steadview Capital has made back-to-back partial exits from portfolio companies taking advantage of...
